To understand processes and the impact of implementing a screening and decision support system for risk of non-diabetic CKD in African American patients with hypertension and/or family history of renal failure, ~40 participants will be genotyped for three risk variants in exon 6 of APOL1. A catalog of current evidence-based guidelines for the management of hypertension and chronic kidney disease will group the participants into three renal care advice message categories including (i) evaluation of CKD, (ii) identification of CKD progression, and (iii) prevention of CKD progression. The gene discussed is APOL1; the disease is chronic kidney disease.